Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"We are really excited about joining forces with Google, the leading tech company when it comes to quantum computing," says Michael Schmelmer, Member of the Board of Managing Directors of Boehringer Ingelheim with responsibility for Finance and Corporate Functions. "Quantum computing has the potential to significantly accelerate and enhance R&D processes in our industry. Quantum computing is still very much an emerging technology. However, we are convinced that this technology could help us to provide even more humans and animals with innovative and groundbreaking medicines in the future."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
INGELHEIM, Germany & MOUNTAIN VIEW, Calif. -- Businesswire -- Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations. The new partnership combines Boehringer Ingelheim’s leading expertise in the field of computer-aided drug design and in silico modeling with Google’s outstanding resources as one of the leading developers of quantum computers and algorithms. Boehringer Ingelheim is the first pharmaceutical company worldwide to join forces with Google in quantum computing. The partnership is designed for three years and is co-led by the newly established Quantum Lab of Boehringer Ingelheim.
“We are really excited about joining forces with Google, the leading tech company when it comes to quantum computing,” says Michael Schmelmer, Member of the Board of Managing Directors of Boehringer Ingelheim with responsibility for Finance and Corporate Functions. “Quantum computing has the potential to significantly accelerate and enhance R&D processes in our industry. Quantum computing is still very much an emerging technology. However, we are convinced that this technology could help us to provide even more humans and animals with innovative and groundbreaking medicines in the future.”
The new collaboration is part of Boehringer Ingelheim’s comprehensive digital transformation strategy with the aim to better leverage and accelerate the company’s promising pipeline and ultimately bringing more medical breakthroughs to patients in need. Boehringer Ingelheim is significantly increasing its investment in a broad range of digital technologies, encompassing key areas such as Artificial Intelligence (AI), machine learning, and data science to better understand diseases, their drivers and biomarkers, and digital therapeutics.
“Extremely accurate modelling of molecular systems is widely anticipated as among the most natural and potentially transformative applications of quantum computing. Therefore, Google is excited to partner with Boehringer Ingelheim to explore use cases and methods for quantum simulations of chemistry. Boehringer Ingelheim brings both an impressive quantum computing team and deep expertise in real world applications of these capabilities in the pharmaceuticals space,” says Ryan Babbush, Head of Quantum Algorithms at Google.
Computational approaches are already a cornerstone in the design and development of innovative new medicines, making a significant contribution to improving the health of humans and animals. However, given their algorithm structure, today's computers are not able to solve many of the real complex challenges which are essential for the early stages of pharmaceutical R&D, most importantly simulating and analyzing molecules related to disease mechanisms. Quantum computing has the potential to accurately simulate and compare much larger molecules than currently possible, creating new opportunities for pharmaceutical innovation and therapies for a range of diseases.“
Researching and developing new, groundbreaking therapies for diseases with high unmet medical need is what our work at Boehringer Ingelheim is all about,” says Michel Pairet, Member of the Board of Managing Directors of Boehringer Ingelheim with responsibility for the company’s Innovation Unit. “Together with Google, our goal is to apply the use of quantum computing in biopharmaceutical R&D and thus continue to make a decisive contribution to medical progress for patients around the world.”
“The thought leadership of Boehringer Ingelheim's quantum research effort is very impressive. This is reflected in the quick turnaround time that their strong quantum research team got assembled, and their commitment to open research. We are looking forward to jointly working on the field with fundamental research and a joint vision for solving relevant pharma problems in the beyond-classical regime over the next decade,” says Markus Hoffmann, Google Quantum AI Partnerships.
Boehringer Ingelheim will invest significantly in the coming years to realize the full potential of quantum computing. The company has already set up a dedicated Quantum Lab and hired outstanding experts in the field of quantum computing from academia, industry, and quantum providers. Partnerships from Industry and Academia will complement the respective teams. Colleagues mainly from the Boehringer Ingelheim’s Innovation Unit and IT support these experts in their work.
Please click on the following link for ‘Notes to Editors’:
http://www.boehringer-ingelheim.com/press-release/partnering-google-quantum-computing
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005440/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Boehringer Ingelheim International GmbH
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 한화, 영국 서리대학과 우주사업 MOU 체결… 우주산업 글로벌 협력 강화 - 뉴스와이어
- KG 모빌리티, 2024년 상반기 흑자 기록 - 뉴스와이어
- 한화그룹, 3개 계열사 대표이사 내정 인사 발표 - 뉴스와이어
- 평화의 섬 제주에서 공존을 꿈꾸며 전하는 메시지… 전시회 ‘내가 만든 세상’ 풍성한 콘텐츠
- 대한전선, 신용등급 A로 상향… 안정적 사업 및 영업수익성 - 뉴스와이어
- Lifeite, 신제품 공기 순환 선풍기 출시… 가정의 시원함을 새롭게 경험하다 - 뉴스와이어
- 포스트 아포칼립틱 도시 건설 게임 ‘엔드존 2’ 얼리 액세스 버전 8월 26일 대공개 - 뉴스와이어
- ‘장마 끝나면 폭염 온다’ 삼성스토어, 에어컨 판매량 급증 - 뉴스와이어
- 스타피쉬엔터테인먼트, 트위치 최상위 여자 스트리머 중 한명인 겨우디 전속계약 - 뉴스와이어
- 아이마이폰, AI 프로그램 2종 출시… AI 영상 제작 도구 ‘Novi AI’와 다기능 AI 도구 ‘ChatArt’ - 뉴